A more recent demonstration of this association in a larger, free-living population comes from the Insulin Resistance Atherosclerosis Risk (IRAS) Study.17 Here (Figure 4), Festa et al. demonstrated a monotonic increase in CRP levels with the presence of an increasing number of metabolic syndrome abnormalities. This evidence concerns the gene CRP and metabolic syndrome.